Gnoth Christian, Markhinin Vitaly, Maxrath Beatrice, Skonieczny Therese, Friol Kerstin, Roos Judith, Rahimi Gohar, Godehardt Erhard
Green-IVF, Grevenbroich Endocrinology and IVF-Center, Rheydter Str. 143, 41515, Grevenbroich, Germany,
Arch Gynecol Obstet. 2015 Mar;291(3):663-9. doi: 10.1007/s00404-014-3448-5. Epub 2014 Sep 6.
There is an ongoing debate whether the source of sperm cells, the etiology or the extent of male factor infertility has influence on the outcome of ICSI cycles.
The results of intracytoplasmic sperm injection (ICSI) according to the source of spermatozoa in patients with severe male factor infertility were compared in a retrospective study: 249 couples underwent a total of 337 fresh ICSI cycles with the use of fresh motile testicular or fresh motile ejaculated spermatozoa.
For all variables, there were no statistically significant differences in the ICSI results between both groups. Fertilization rates were 46.8% for testicular and 47.6% for ejaculated spermatozoa. Live birth rates per embryo transfer were 20.4% using testicular spermatozoa and 22.8% using ejaculated spermatozoa.
Neither the source of spermatozoa nor the etiology of severe male infertility has relevant impact on the results of ICSI cycles as long as fresh motile, morphologically normal spermatozoa are used. Therefore, in case of cryptozoospermia, we recommend to preferentially use ejaculated spermatozoa to prevent those men from an unnecessary testicular biopsy avoiding risks and costs implied.
关于精子细胞来源、男性因素不育的病因或程度是否会影响卵胞浆内单精子注射(ICSI)周期的结果,目前仍存在争议。
在一项回顾性研究中,比较了重度男性因素不育患者根据精子来源进行的卵胞浆内单精子注射(ICSI)结果:249对夫妇共进行了337个新鲜ICSI周期,使用的是新鲜活动的睾丸精子或新鲜活动的射出精子。
对于所有变量,两组间ICSI结果无统计学显著差异。睾丸精子的受精率为46.8%,射出精子的受精率为47.6%。每次胚胎移植的活产率,使用睾丸精子为20.4%,使用射出精子为22.8%。
只要使用新鲜活动、形态正常的精子,精子来源和重度男性不育的病因均对ICSI周期结果无相关影响。因此,对于隐匿性无精子症患者,我们建议优先使用射出精子,以避免这些男性进行不必要的睾丸活检,从而规避相关风险和费用。